Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Are climate change and air pollution triggering cardiovascular disease?
Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...
Making Inexpensive Insulin Using Microalgae
This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...
Fancy footwork: How different are the feet of zoo and wild giraffe?
Cooperative training helps zookeepers care for zoo animals. For giraffe, much of this training focuses on...